Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

The Affordable Care Act and Access to Care for Reproductive-Aged and Pregnant Women in the United States, 2010-2016.

Daw JR, Sommers BD.

Am J Public Health. 2019 Apr;109(4):565-571. doi: 10.2105/AJPH.2018.304928. Epub 2019 Feb 21.

PMID:
30789761
2.

Preconception Coverage Before and After the Affordable Care Act Medicaid Expansions.

Clapp MA, James KE, Kaimal AJ, Daw JR.

Obstet Gynecol. 2018 Dec;132(6):1394-1400. doi: 10.1097/AOG.0000000000002972.

PMID:
30399105
3.

Matching in Difference-in-Differences: between a Rock and a Hard Place.

Daw JR, Hatfield LA.

Health Serv Res. 2018 Dec;53(6):4111-4117. doi: 10.1111/1475-6773.13017. Epub 2018 Jul 25. No abstract available.

PMID:
30047131
4.

Matching and Regression to the Mean in Difference-in-Differences Analysis.

Daw JR, Hatfield LA.

Health Serv Res. 2018 Dec;53(6):4138-4156. doi: 10.1111/1475-6773.12993. Epub 2018 Jun 29.

PMID:
29957834
5.

Association of the Affordable Care Act Dependent Coverage Provision With Prenatal Care Use and Birth Outcomes.

Daw JR, Sommers BD.

JAMA. 2018 Feb 13;319(6):579-587. doi: 10.1001/jama.2018.0030.

6.

Immigration, Pregnancy, and Heath Insurance: New Evidence and Ongoing Debate.

Daw JR, Sommers BD.

Obstet Gynecol. 2017 Nov;130(5):935-937. doi: 10.1097/AOG.0000000000002338. No abstract available.

PMID:
29016503
7.

Women In The United States Experience High Rates Of Coverage 'Churn' In Months Before And After Childbirth.

Daw JR, Hatfield LA, Swartz K, Sommers BD.

Health Aff (Millwood). 2017 Apr 1;36(4):598-606. doi: 10.1377/hlthaff.2016.1241.

PMID:
28373324
8.

Seeking safe stool: Canada needs a universal donor model.

Edelstein C, Daw JR, Kassam Z.

CMAJ. 2016 Dec 6;188(17-18):E431-E432. doi: 10.1503/cmaj.150672. Epub 2015 Dec 22. No abstract available.

9.

Estimated cost of universal public coverage of prescription drugs in Canada.

Morgan SG, Law M, Daw JR, Abraham L, Martin D.

CMAJ. 2015 Apr 21;187(7):491-497. doi: 10.1503/cmaj.141564. Epub 2015 Mar 16.

10.

Framing incremental expansions to public health insurance systems: the case of Canadian pharmacare.

Daw JR, Morgan SG, Collins PA, Abelson J.

J Health Polit Policy Law. 2014 Apr;39(2):295-330. doi: 10.1215/03616878-2416229.

PMID:
24711215
11.

Use of product listing agreements by Canadian provincial drug benefit plans.

Morgan SG, Friesen MK, Thomson PA, Daw JR.

Healthc Policy. 2013 May;8(4):45-55.

12.

Canadian pharmacare: looking back, looking forward.

Morgan SG, Daw JR.

Healthc Policy. 2012 Aug;8(1):14-23.

13.

Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis.

Puyat JH, Daw JR, Cunningham CM, Law MR, Wong ST, Greyson DL, Morgan SG.

Soc Psychiatry Psychiatr Epidemiol. 2013 Dec;48(12):1861-72. doi: 10.1007/s00127-013-0753-4. Epub 2013 Aug 14. Review.

PMID:
23942793
14.

Canadian policy makers' views on pharmaceutical reimbursement contracts involving confidential discounts from drug manufacturers.

Morgan SG, Thomson PA, Daw JR, Friesen MK.

Health Policy. 2013 Oct;112(3):248-54. doi: 10.1016/j.healthpol.2013.05.022. Epub 2013 Jun 25.

15.

Here today, gone tomorrow: the issue attention cycle and national print media coverage of prescription drug financing in Canada.

Daw JR, Morgan SG, Thomson PA, Law MR.

Health Policy. 2013 Apr;110(1):67-75. doi: 10.1016/j.healthpol.2013.01.006. Epub 2013 Feb 16.

PMID:
23419420
16.

Growth in private payments for health care by Canadian households.

Law MR, Daw JR, Cheng L, Morgan SG.

Health Policy. 2013 May;110(2-3):141-6. doi: 10.1016/j.healthpol.2013.01.014. Epub 2013 Feb 16.

PMID:
23419418
17.

Inter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provinces.

Morgan SG, Thomson PA, Daw JR, Friesen MK.

BMC Health Serv Res. 2013 Jan 31;13:34. doi: 10.1186/1472-6963-13-34.

18.

Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).

Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG.

Clin Ther. 2012 Jan;34(1):239-249.e2. doi: 10.1016/j.clinthera.2011.11.025. Epub 2011 Dec 14.

PMID:
22169049
19.

Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010.

Daw JR, Morgan SG.

Health Policy. 2012 Jan;104(1):19-26. doi: 10.1016/j.healthpol.2011.08.015. Epub 2011 Oct 5.

20.

Prescription drug use during pregnancy in developed countries: a systematic review.

Daw JR, Hanley GE, Greyson DL, Morgan SG.

Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):895-902. doi: 10.1002/pds.2184. Epub 2011 Jul 20. Review.

21.

Medical utilization associated with palivizumab compliance in a commercial and managed medicaid health plan.

Diehl JL, Daw JR, Coley KC, Rayburg R.

J Manag Care Pharm. 2010 Jan-Feb;16(1):23-31.

22.

Modified nasal alveolar molding appliance for management of cleft lip defect.

Da Silveira AC, Oliveira N, Gonzalez S, Shahani M, Reisberg D, Daw Jr JL, Cohen M.

J Craniofac Surg. 2003 Sep;14(5):700-3.

PMID:
14501332
23.

Functional effects of protein kinase C activation on the human cardiac Na+ channel.

Murray KT, Hu NN, Daw JR, Shin HG, Watson MT, Mashburn AB, George AL Jr.

Circ Res. 1997 Mar;80(3):370-6.

PMID:
9048657

Supplemental Content

Support Center